PALI Dinamika bathi saben saham ing taun lumaku palisadebio.com

Simbol resmi perusahaan Palisade Bio, Inc. (PALI)

Palisade Bio, Inc. (PALI) develops unique enzyme inhibitors to protect the gastrointestinal tract during surgery, leveraging its scientific potential. The annual earnings per share trend illustrates the asset's dynamics, where 22.10 indicates the value of this parameter. The brand is gaining recognition among surgeons by reducing rehabilitation times; however, a lack of revenue and the costs of clinical trials limit the scaling of the pipeline.

Wutah bathi saben saham ing taun lumaku palisadebio.com (PALI): kanggo periode 04.07.2022 - 12.11.2026

Rincian analitis lan laporan data perusahaan Palisade Bio, Inc. (PALI)

- rega saham lan prakiraan rega para ahli:
Rega Palisade Bio Inc.|PALI - Bagan rega target
- data kapitalisasi pasar:
Biji pasar Palisade Bio, Inc.|PALI - Nilai Perusahaan
- statistik nilai buku emiten:
Nilai Buku saben Saham Palisade Bio|PALI - Nilai Buku Perusahaan|Rasio Nilai Pasar marang Nilai Buku palisadebio.com|PALI - Total Aset Perusahaan
- indikator beban utang lan likuiditas:
Koefisien Total Utang marang Modal Palisade Bio, Inc.|PALI - Utang jangka dawa marang ekuitas|Koefisien utang jangka cendhak marang modal palisadebio.com|PALI - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Palisade Bio, Inc.|PALI - Utang jangka dawa perusahaan|Tanggungan utang jangka cendhak perusahaan Palisade Bio|Likuiditas darurat palisadebio.com
- rincian bathi lan kelipatan pasar:
PALI - Penghasilan resik|Penghasilan resik sing dikarepake Palisade Bio, Inc.|PALI - Pangali P/E|Rega marang bathi mangsa ngarep Palisade Bio Inc.|PALI - Pangali PEG|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan Palisade Bio, Inc.|PALI - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben siji saham sajrone rolas wulan pungkasan Palisade Bio|PALI - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan palisadebio.com|PALI - Wutah bathi ing taun lumaku|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Palisade Bio, Inc.
Pambiji fundamental:Palisade Bio, Inc.
Produk seri Palisade Bio, Inc.

The year-over-year percentage change in net income per share for Palisade Bio, Inc. (PALI) reflects the actual efficiency of capitalizing on gastrointestinal targeted therapy. This metric measures the growth rate of shareholder value, allowing investors to filter out speculative noise from fundamental growth. By analyzing the history of annual earnings per share changes, an investor can confirm that the brand's high scientific reputation is converting into sustainable financial development.

Pesaing langsung

PHAT: Wutah bathi resik saben siji saham kanggo taun lumaku|Wutah bathi saben saham ing taun lumaku Terns Pharmaceuticals Inc|Ironwood Pharmaceuticals Inc - Dinamika bathi saben saham ing taun lumaku|Wutah bathi ing taun lumaku CURX|Wutah bathi ing taun lumaku immuron.com.au (IMRN)|Wutah bathi saben saham ing taun lumaku Evoke Pharma EVOK|Entero Therapeutics Inc. - Wutah bathi saben saham ing taun lumaku|RedHill - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun iki Jaguar Health Corp JAGX|Biora Therapeutics (BIOR) - Wutah bathi saben saham ing taun lumaku|MORF - Prakiraan wutah bathi resik saben saham ing taun iki